Investing Profile

David Goeddel


Managing Partner at The Column Group, California
Photo of David Goeddel, Managing Partner at The Column Group

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
The Column Group Managing Partner
$100K - $1M
CompanyStageDateRound SizeTotal Raised
Hexagon Bio
Series BSep 2021$61M
Series ASep 2020$47M
Co-investors: Millie Ray (The Column Group), Jakob Loven (Nextech Invest), Dusan Perovic (Two Sigma Ventures), Alex Kolicich (8VC)
Exonics Therapeutics
Series ANov 2017$40M
Peloton Therapeutics
Series DSep 2016$52.4M
NGM Biopharmaceuticals
Series DMar 2015$57.5M
Co-investors: Peter Svennilson (The Column Group)
Flexus Biosciences
Series BDec 2014$38M
Co-investors: Beth Seidenberg (Kleiner Perkins)
Nurix Therapeutics
Series BMay 2014$25.1M
Seed RoundMay 2012$3.1M
Series CJan 2014$14M
Series CJun 2012$33M
Co-investors: Richard Ulevitch (5am Ventures)
Constellation Pharmaceuticals
Series CJan 2012$95M
Co-investors: Robert Tepper (Third Rock Ventures), Tony Evnin (Venrock), Brian Gallagher (Abingworth)